Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Hogan

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Toxicology Reports|May 9, 2020
Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapyBlessy George, Xia Wen, Nickie Mercke, et al.
Kidney International|September 16, 2011
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritisSean J Barbour, Allen Greenwald, Ognjenka Djurdjev, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2023
Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 GenotypeDhruti P Chen, Candace D Henderson, Jaeline Anguiano, et al.
Clinical Pharmacology and Therapeutics|December 22, 2016
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical NephrotoxicityBlessy George, Xia Wen, Nickie Mercke, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGSLouis-Philippe Laurin, Adil M Gasim, Caroline J Poulton, et al.
Women'S Health (London, England)|January 27, 2024
Prevalence of infertility and pregnancy loss among individuals with kidney disease in the Hispanic Community Health Study/Study of LatinosMonica L Reynolds, Laura R Loehr, Susan L Hogan, et al.
European Journal of Clinical Pharmacology|August 12, 2009
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseasesMelanie S Joy, Kimberly Dornbrook-Lavender, Joyce Blaisdell, et al.
Arthritis and Rheumatism|October 2, 2012
Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosisSophia Lionaki, Elizabeth R Blyth, Susan L Hogan, et al.
Seminars in Arthritis and Rheumatism|September 19, 2017
Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitisCarolyn T Thorpe, Joshua M Thorpe, Tao Jiang, et al.
Canadian Journal of Kidney Health and Disease|May 1, 2015
A population-based study of prevalence and risk factors of chronic kidney disease in León, NicaraguaJill F Lebov, Eliette Valladares, Rodolfo Peña, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Toxicology Reports|May 9, 2020
Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapyBlessy George, Xia Wen, Nickie Mercke, et al.
Kidney International|September 16, 2011
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritisSean J Barbour, Allen Greenwald, Ognjenka Djurdjev, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2023
Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 GenotypeDhruti P Chen, Candace D Henderson, Jaeline Anguiano, et al.
Clinical Pharmacology and Therapeutics|December 22, 2016
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical NephrotoxicityBlessy George, Xia Wen, Nickie Mercke, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGSLouis-Philippe Laurin, Adil M Gasim, Caroline J Poulton, et al.
Women'S Health (London, England)|January 27, 2024
Prevalence of infertility and pregnancy loss among individuals with kidney disease in the Hispanic Community Health Study/Study of LatinosMonica L Reynolds, Laura R Loehr, Susan L Hogan, et al.
European Journal of Clinical Pharmacology|August 12, 2009
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseasesMelanie S Joy, Kimberly Dornbrook-Lavender, Joyce Blaisdell, et al.
Arthritis and Rheumatism|October 2, 2012
Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosisSophia Lionaki, Elizabeth R Blyth, Susan L Hogan, et al.
Seminars in Arthritis and Rheumatism|September 19, 2017
Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitisCarolyn T Thorpe, Joshua M Thorpe, Tao Jiang, et al.
Canadian Journal of Kidney Health and Disease|May 1, 2015
A population-based study of prevalence and risk factors of chronic kidney disease in León, NicaraguaJill F Lebov, Eliette Valladares, Rodolfo Peña, et al.
Pageof 14